Universal Technical Institute (UTI) has rolled out a blended learning model across its technician programs, combining online coursework with in-person labs. This shift puts program design and workforce alignment squarely in focus for investors.

UTI’s blended learning rollout comes as its share price has moved sharply higher, with a 20.15% 1 month share price return and a 50.24% year to date share price return, alongside a very large 3 year total shareholder return that signals strong longer term momentum.

If you are thinking beyond a single education stock, this is a good moment to broaden your watchlist and check out 20 top founder-led companies

With shares now near the average analyst price target and an intrinsic value estimate implying a premium instead of a discount, you have to ask yourself: is there still upside here, or is the market already pricing in future growth?

Price to earnings of 38.2x: Is it justified?

On a P/E of 38.2x, UTI is priced well above both its own fair P/E estimate and the broader Consumer Services space. This points to a rich valuation at the current $37.32 share price.

The P/E ratio compares a company’s share price to its earnings per share and is a quick way to see how much investors are paying for each dollar of current earnings. For a career education provider like UTI, a higher P/E can indicate that the market expects solid earnings growth or sees the earnings base as relatively dependable.

Here, the market is assigning UTI a 38.2x P/E, while the estimated fair P/E sits at 20.7x. That gap suggests investors are willing to pay a premium multiple for its earnings, even though earnings are forecast to grow 15.5% per year, which is close to, but not above, the broader US market forecast. With UTI also trading above the SWS DCF estimate of $2.36 per share, the current pricing reflects strong expectations already baked in.

The premium is even clearer when lining UTI up against peers. The US Consumer Services industry average P/E is 16.9x, so UTI’s 38.2x sits more than twice that level. Compared to both its fair P/E estimate of 20.7x and its sector average, the current multiple indicates that the market is valuing UTI at a high earnings premium that could compress if expectations reset closer to those benchmarks.

Result: Price-to-earnings of 38.2x (OVERVALUED).

However, you still need to weigh execution risks in blended learning, as well as any shift in student demand that could challenge the current premium valuation.

Another angle on value: cash flows paint the same picture

UTI already looks expensive on a 38.2x P/E, and the SWS DCF model points in the same direction. With the share price at $37.32 versus a DCF value estimate of $2.36 per share, the gap reinforces that a lot of optimism is already in the price. Where does that leave your risk appetite?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Universal Technical Institute for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With sentiment this strong around UTI, it helps to look past the headline metrics and into the details yourself. Then decide how comfortable you are with the balance of optimism and concern. To see how that balance currently looks, take a closer look at the 1 key reward and 1 important warning sign.

Looking for more investment ideas?

If UTI is already on your radar, do not stop there. Broaden your opportunity set with a few focused stock ideas that match different investing goals.

• Target potential mispricing by scanning companies that combine quality fundamentals with attractive valuations using the 49 high quality undervalued stocks.
• Prioritise resilience by checking out businesses that score well on financial strength through the solid balance sheet and fundamentals stocks screener (40 results).
• Hunt for potential future standouts among lesser known names by running the screener containing 25 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.